메뉴 건너뛰기




Volumn 15, Issue 11, 2007, Pages 3728-3736

Structure based de novo design of novel glycogen synthase kinase 3 inhibitors

Author keywords

De novo design; GSK 3; Ludi; Molecular docking; Structure based design

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; BISARYLMALEIMIDE 1; BISARYLMALEIMIDE 2; CT 2006; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; HYMENIALDISINE; HYMENIALDISINE 1; HYMENIALDISINE 2; INDIRUBIN 1; INDIRUBIN 2; INDOLYLYLMALEIMIDE 1; INDOLYLYLMALEIMIDE 2; PAULLONE 1; PAULLONE 2; PYRAZOLOPYRIDAZINE 1; PYRAZOLOPYRIDAZINE 2; PYRAZOLOPYRIMIDINE 1; PYRAZOLOPYRIMIDINE 2; UNCLASSIFIED DRUG;

EID: 34247544379     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2007.03.048     Document Type: Article
Times cited : (9)

References (52)
  • 36
    • 34247514849 scopus 로고    scopus 로고
    • 2 program, Accelrys Inc, San Diego, CA, USA.
  • 43
    • 34247524199 scopus 로고    scopus 로고
    • SYBYL6.9, Tripos Inc, 1699 South Hanley Rd, St. Louis, MO 63144, USA.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.